| Mepha Pharma AG - Buprenorphin-Mepha 8 mg, Sublingualtabletten | | 65188 | | 03 | | Buprenorphin-Mepha 8 mg | | Sublingualtabletten | | N07BC01 | | Buprenorphin | | 12.12.2014 | | |
| | Composition | | buprenorphinum 8 mg ut buprenorphini hydrochloridum 8.64 mg, magnesii stearas, crospovidonum, natrii citras anhydricus corresp. natrium 1.872 mg, povidonum K 29-32, acidum citricum, amylum pregelificatum, mannitolum, lactosum monohydricum 175.6 mg, E 110 0.76 mg, pro compresso. | | Packungsbestandteile | | Comprimés sublinguaux | | | | | Principe actif | Concentr. |
|---|
| Buprenorphine | 8 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Buprenorphine | 8 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique | | | | Amylum Pregelificatum | | | | Crospovidonum | | | | E 110 | 0.76 mg | color. | | Lactose Monohydrate | 175.6 mg | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Citras Anhydricus | | | | Povidonum K | 29-32 | | | Pro Compresso | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 7 Comprimé(s) | 19.65 | 37.80 | A+ | LS | Non | | 006 | 28 Comprimé(s) | 72.45 | 95.20 | A+ | LS | Non |
|
|
